Drug reviewers to hit the books

FDA reviewers can look forward to a break in their daily routine for education on advanced pharmaceutical manufacturing and technology.

Under a $652,000 contract just awarded by the regulator, the National Institute for Pharmaceutical Technology and Education (NIPTE) and Duquesne University will collaborate to develop educational content for the FDA Office of Pharmaceutical Science. OPS staff includes those who review and evaluate the quality-related information for new drug applications.

NIPTE will work with the OPS to identify education needs and then make recommendations on training areas. The educators will develop and deliver the content and assess its effectiveness in helping students with their review, research and policy-making activities. 

The  program is expected to run through September 2011.

- see the NIPTE announcement

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.